Duramed (DRMD) Synthetic Estrogen Product Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: vestor who wrote (930)	3/24/1999 10:11:00 PM
From: Thure Meyer	Read Replies (1) of 1837

The overall market in the US is $2-billion plus with annual projected growth rate of 15% (given that a lot of baby boomers are coming on-line), but this information is available in the news item. If 20% does happen in 12-18 months, that translates into a cool 400 million in revenue. Of course all of that would not be Durameds since they couldn't handle the marketing part and will be working with partners. But the great news is that the Duramed float is less than 20 million shares. Think of that. I don't really want to speculate, but if they get $5-10 earnings per share at at conservative P/E of 15, then we are looking at a real gusher. But, lets wait for the opening. The next phase will be to analyze longer term prospects. If I can hold off selling your shares it may be the best investment I ever made. Thure

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next